Published in Eur Respir J on October 01, 1994
Health status measurement in chronic obstructive pulmonary disease. Thorax (2001) 3.07
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis (2007) 1.37
Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). J Nutr (2015) 1.20
Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respir Med (2009) 1.18
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res (2007) 1.10
Long-term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice. Dis Model Mech (2012) 1.08
Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res (2001) 1.04
Body mass index and mortality in elderly men and women: the Tromso and HUNT studies. J Epidemiol Community Health (2011) 0.99
Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis (2012) 0.96
Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med (2010) 0.95
Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD. Thorax (2006) 0.88
A practical guide to bioelectrical impedance analysis using the example of chronic obstructive pulmonary disease. Nutr J (2011) 0.88
Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease. Respir Res (2010) 0.88
Structural alterations of skeletal muscle in copd. Front Physiol (2014) 0.85
Upper limb muscle strength & endurance in chronic obstructive pulmonary disease. Indian J Med Res (2013) 0.85
Predictors' factors of nutritional status of male chronic obstructive pulmonary disease patients. ISRN Nurs (2012) 0.84
Respiratory muscle function and free radicals: from cell to COPD. Thorax (2000) 0.84
Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones. Eur J Nutr (2012) 0.84
Enhancing physical performance in chronic obstructive pulmonary disease. Thorax (2001) 0.83
Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.83
High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1). J Biol Chem (2015) 0.83
Plasma orexin-a levels in COPD patients with hypercapnic respiratory failure. Mediators Inflamm (2011) 0.81
Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective. J Cachexia Sarcopenia Muscle (2015) 0.79
Mechanisms of physical activity limitation in chronic lung diseases. Pulm Med (2012) 0.78
Body composition in patients with chronic obstructive pulmonary disease. Maedica (Buchar) (2014) 0.78
Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle. Am J Physiol Lung Cell Mol Physiol (2012) 0.78
The impact of body mass index on inpatient- versus outpatient-treated chronic obstructive pulmonary disease exacerbations. Can Respir J (2013) 0.77
Dietary intake of patients with moderate to severe COPD in relation to fat-free mass index: a cross-sectional study. Nutr J (2015) 0.77
Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls. Respir Res (2015) 0.76
Peak anaerobic power in patients with COPD: gender related differences. Eur J Appl Physiol (2006) 0.76
Ambulatory pulse oximetry monitoring in Japanese COPD outpatients not receiving oxygen therapy. Multidiscip Respir Med (2014) 0.75
Electrical stimulation influences chronic intermittent hypoxia-hypercapnia induction of muscle fibre transformation by regulating the microRNA/Sox6 pathway. Sci Rep (2016) 0.75
Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.75
Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth. Mol Ther Nucleic Acids (2016) 0.75
Plasma orexin-A and ghrelin levels in patients with chronic obstructive pulmonary disease: Interaction with nutritional status and body composition. Exp Ther Med (2014) 0.75
Relationship between nutritional risk and exercise capacity in severe chronic obstructive pulmonary disease in male patients. Int J Chron Obstruct Pulmon Dis (2015) 0.75
The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients. Lung (2017) 0.75
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax (2009) 3.12
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ (2002) 2.35
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med (1999) 2.03
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med (2001) 1.96
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax (1996) 1.94
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
Use of out of hours services: a comparison between two organisations. Emerg Med J (2003) 1.89
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J (2001) 1.88
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax (1991) 1.79
Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.73
Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J (1999) 1.62
Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther (1990) 1.61
Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest (1997) 1.60
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr (2000) 1.58
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem (2001) 1.55
Postoperative pulmonary function abnormalities after coronary artery bypass surgery. Respir Med (1992) 1.53
Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1998) 1.51
Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) (1999) 1.49
Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.47
Evaluation of quality of life in sarcoidosis patients. Respir Med (1998) 1.40
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
External validation of a COPD diagnostic questionnaire. Eur Respir J (2007) 1.33
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med (1995) 1.25
Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord (2001) 1.22
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.21
Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol (2000) 1.20
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol (2000) 1.14
Adverse effects of the indoor environment on respiratory health in primary school children. Environ Res (1995) 1.14
Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.13
Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol (2001) 1.10
Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med (1998) 1.09
The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr (1995) 1.07
Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 1.06
Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr (1999) 1.06
Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.04
Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr (1998) 1.04
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J (2007) 1.03
Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J (1997) 1.01
Interval versus continuous training in patients with severe COPD: a randomized clinical trial. Eur Respir J (1999) 1.01
Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.01
Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.01
Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.00
Chronic obstructive pulmonary disease: evaluation with spirometrically controlled CT lung densitometry. Radiology (1994) 0.99
Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99
Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 0.99
Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol (1998) 0.98
Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr (1990) 0.97
Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J (2009) 0.97
Resting energy expenditure in patients with non-small cell lung cancer. Cancer (1991) 0.97
Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect (1996) 0.97
Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J (1999) 0.97
Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med (1998) 0.95
BAL fluid LDH activity and LDH isoenzyme pattern in lipoid pneumonia caused by an intravenous injection of lamp oil. Eur Respir J (1996) 0.95
Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system. Lung Cancer (2011) 0.95
Decreased mechanical efficiency in clinically stable patients with COPD. Thorax (1997) 0.94
Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond) (1997) 0.94
Analysis of the energy balance in lung cancer patients. Cancer Res (1994) 0.94
Diagnostic value of BAL fluid cellular profile and enzymes in infectious pulmonary disorders. Eur Respir J (1999) 0.93
Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J (2001) 0.92
Thoracoscopic pleurodesis in the management of spontaneous pneumothorax. Respiration (1988) 0.92
Within-day variation of bioelectrical resistance measurements in patients with chronic obstructive pulmonary disease. Clin Nutr (1990) 0.92
N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis. Eur Respir J (1999) 0.92